VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 71 filers reported holding VERONA PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,429,461 | +7.8% | 87,697 | +39.8% | 0.00% | – |
| Q2 2023 | $1,326,048 | -14.9% | 62,727 | -19.2% | 0.00% | – |
| Q1 2023 | $1,558,309 | +45.8% | 77,605 | +89.7% | 0.00% | – |
| Q4 2022 | $1,068,691 | +7533.5% | 40,899 | +2863.7% | 0.00% | – |
| Q3 2022 | $14,000 | +100.0% | 1,380 | -17.7% | 0.00% | – |
| Q2 2022 | $7,000 | +133.3% | 1,677 | +181.8% | 0.00% | – |
| Q1 2022 | $3,000 | -57.1% | 595 | -40.0% | 0.00% | – |
| Q4 2021 | $7,000 | -88.3% | 992 | -91.0% | 0.00% | – |
| Q3 2021 | $60,000 | +172.7% | 11,070 | +230.0% | 0.00% | – |
| Q2 2021 | $22,000 | +633.3% | 3,355 | +724.3% | 0.00% | – |
| Q4 2020 | $3,000 | – | 407 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
| Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
| NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
| Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
| Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
| Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
| RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
| Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
| Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |